Topical Psoriasis Study for Patients Receiving Biologic Therapy

Summary

A two-phase, single center, study of 20 subjects to assess 4 weeks of add-on therapy of Topicort® BID and 12 weeks BID on two consecutive days a week to patients with ≤5% BSA who are receiving biologic therapy for at least 24 weeks

Timeline

Start

2016-03

Primary completion

2016-09

Completion

2016-10

Drugs

Indications